CPIX — Cumberland Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $127.21m
- $123.01m
- $44.52m
Cumberland Pharma rises as drug helps treat bacterial infection in COVID-19 patients
Brief: Cumberland Pharma- Released Series Of Case Reports Describing Effectiveness Of Vibativ In Treating Secondary Bacterial Infections In Covid-19 Patients
Brief: Cumberland Pharmaceuticals Inc Says Received A Formal Notice From SBA That Full Amount Of Loan Pursuant To PPP Is Forgiven
Brief: Cumberland Pharmaceuticals Names John Hamm New CFO
Brief: Cumberland Pharmaceuticals Says Board Has Appointed John Hamm As CFO Effective May 17
Cumberland Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update
Cumberland Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Cumberland Pharmaceuticals Reports Q4 Adj Earnings Per Share Of $0.01
Brief: Cumberland Pharmaceuticals Files For Mixed Shelf Of Up To $100 Mln – SEC Filing
Brief: Cumberland Pharmaceuticals Reports Q3 2020 Results
Brief: Cumberland Enters Third Amendment To Revolving Credit Note, Fourth Amendment To Revolving Credit Loan Agreement
Brief: Cumberland Pharmaceuticals Reports Q2 Loss Per Share Of $0.06
Brief: Cumberland Posts Q1 Adjusted EPS Of $0.01
Brief: To Help Prepare For The Covid-19 Patient Surge Cumberland Pharmaceuticals Expands Availability Of Vaprisol® To Treat Hyponatremia In Critical Care Units
Brief: Cumberland To Expand Availability Of Caldolor For High Fever Associated With Coronavirus
Brief: Cumberland Pharmaceuticals Inc - Initiative Designed To Help Address Potential Antibiotic Shortages
Brief: Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019
Brief: Cumberland Pharma - Launched Caldolor Injection In A Ready-To-Use Bag That May Be Administered Without Dilution